AR2I

What AR2I does

AR2I is presented in the firmographic record as a France-based for-profit contract research organization providing chemical analysis services to the pharmaceutical, parapharmaceutical, and cosmetic fields, founded in 1994 and headquartered in Le Plessis-Robinson. The broader data block describes its operating brand Qualilab, an established French regulated-industry consulting firm operational since 1989 that delivers quality management, regulatory affairs and toxicology, qualification/validation of computerized systems and analytical methods, information-systems compliance support (AMOA/MOA), statistical data analysis, statistical-software sales, and Qualiopi-certified professional training. Service lines cover six vertical end-markets: pharmaceutical industry, biotechnology and medical devices, cosmetics, chemical and phytopharmaceutical, healthcare (hospitals, cancer institutes), and ISO/IEC 17025-accredited laboratories.

The revenue model is professional-services based, with bespoke project-based consulting engagements, multi-year contracts, inter-company training sessions (Qualiopi-certified), and a smaller one-time statistical-software license stream. Distribution is sales-led, executed through direct outreach, inbound interest from event presence, and recurring participation as organizer or co-speaker at industry congresses (A3P Cosmétique, SOFAQ, ACADM, Polepharma Biotesting, Data Management Biomédical). Marketing is concentrated on LinkedIn, the company website (thought leadership on regulatory changes such as ICH E6 R3), and event sponsorship rather than paid acquisition. Customer evidence includes co-marketing relationships with LFB (pharmaceutical enterprise), CHU de Toulouse and Institut Universitaire du Cancer – Oncopole (academic/government), and venue collaboration with Institut Pasteur Lille.

In March 2025 the operating business exited the Neovix-Biosciences group and joined the Biofortis Group as part of a corporate restructuring, providing ecosystem scale and cross-sell potential. Compliance credentials are central to the value proposition: Qualiopi training certification (renewed 2025-10-03) and CAIH re-referencement for 2025-2029 enable ongoing access to French public-sector and hospital engagements. The firm operates solely within France with no evidence of international expansion; headcount is stated as 11-50 and revenue is not disclosed.

Name

AR2I

Legal name

Qualilab

Website

https://ar2i.fr

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

AR2I (operating brand: Qualilab) is a French contract research and consulting firm delivering quality management, regulatory affairs, toxicology, validation, data analysis, statistical software, and Qualiopi-certified training to pharmaceutical, biotech, medical device, cosmetic, chemical, and healthcare clients across France.

Ownership category

akta.pro rank

Headquarters

HQ city

Le Plessis-robinson

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Quality Management Consulting: Billable consulting engagements for quality management including coaching, auditing, and system optimization for private and public sector clients.
2. Regulatory Affairs and Toxicology Services: Regulatory affairs and toxicology consulting engagements for pharmaceutical, biotech, cosmetic, and chemical companies.
3. Qualification and Validation Services: Computerised system and analytical method validation services billed as project-based consulting.
4. Training Programs: Inter-company training sessions delivered in the French market, certified Qualiopi.
5. Statistical Software Sales: Sale of statistical software solutions to clients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

AR2I is a France-based contract research organization that delivers chemical analysis services and regulatory/quality consulting to the pharmaceutical, parapharmaceutical, and cosmetic industries. Its portfolio spans quality management support (coaching, audits, consulting, optimization), regulatory affairs and toxicology consulting, qualification and validation of computerised systems and analytical methods, information systems compliance (AMOA and audits), analytical method support, statistical data analysis, statistical software sales, and Qualiopi-certified professional training.

Product overview

Qualilab is a consulting and services company offering an integrated portfolio of quality management, regulatory affairs, data analysis, and training solutions for the pharmaceutical, biotechnologies, medical devices, cosmetic, and healthcare industries. Founded in 1989, the company operates as a service-based organization providing quality management, information systems qualification/validation, regulatory affairs and toxicology support, analytical support, statistical data analysis, software solutions, and professional training. In March 2025, Qualilab joined the Biofortis group, transitioning from the Neovix-Biosciences group. The services are delivered through studies and system implementation, training and personnel supplementation, assistance and support to existing teams, and internal/external audits.

Differentiator

Problem solved

Functional benefit

Products and services

• Quality Management Services (Management de la Qualité) Comprehensive quality management support for private and public sector clients, including coaching, auditing, consulting, and optimization of quality systems for pharmaceutical, cosmetic, biotechnologies, medical devices, and healthcare organisations.
• Information Systems Services (Système d'Information) AMOA (Assistance à Maîtrise d'Ouvrage), audits, and compliance support for computerised systems in regulated environments, helping clients ensure information-system compliance.
• Regulatory Affairs and Toxicology Consulting (Affaires Réglementaires et Toxicologie) Regulatory affairs and toxicology consulting services for medical devices (DM/IVD), pharmaceutical, cosmetic, and chemical products, supporting submissions, compliance, and toxicology assessment.
• Qualification/Validation Services Qualification and validation of computerised systems and analytical methods for regulated environments, billed as project-based consulting engagements.
• Analytical Support (Support Analytique) Support throughout the lifecycle of analytical and measurement methods, including method validation and verification, for laboratories and regulated-industry clients.
• Data Analysis Services (Analyse de données) Statistical data analysis services for clinical and laboratory data, supporting regulatory submissions and research studies.
• Statistical Software Solutions (Solutions Logicielles) Sale of statistical software solutions providing tools for data analysis and quality management; billed on a one-time license basis.
• Professional Training (Formations) Adaptated training programs for professionals in quality management, regulatory affairs, and analytical methods, delivered as inter-company training sessions with a published calendar; Qualiopi-certified.

Quantifiable outcome

• CAIH re-referencement renewed for 2025-2029 period (20/02/2025 to 27/02/2029)
• +1 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered minor and core.

• CHU de ToulouseminorStrategic or Co-development Partner · 11 June 2026CHU de Toulouse is co-organising the 12th ACADM congress (Rencontres du groupe des Data Managers Académiques) on 6-7 May 2026 in Toulouse alongside Qualilab and Institut Universitaire du Cancer – Oncopole.
• Institut Universitaire du Cancer – OncopoleminorStrategic or Co-development Partner · 10 June 2026Institut Universitaire du Cancer – Oncopole is co-organising the 12th ACADM congress with CHU de Toulouse and Qualilab on 6-7 May 2026 in Toulouse, focused on academic clinical data management.
• LFB (Laboratoire Français du Fractionnement et des Biotechnologies)coreStrategic or Co-development Partner · 10 June 2025At the Polepharma Biotesting congress in June 2025, Qualilab co-presented a conference session with LFB on 'Analytique et statistiques' (analytics and statistics), indicating a collaborative client relationship and joint thought leadership in the pharmaceutical sector.
• Biofortis GroupcoreStrategic or Co-development Partner · 20 March 2025In March 2025, Qualilab exited the Neovix-Biosciences group and joined the Biofortis Group as part of a corporate restructuring. Biofortis Group provides an ecosystem for specialized quality and regulatory services across regulated industries, strengthening Qualilab's market position and cross-selling opportunities.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• SGS: Global testing, inspection, and certification company with a sizable life sciences practice covering pharma quality, regulatory, and clinical services. Overlaps with Qualilab's quality and validation offerings as part of a much wider TIC portfolio.
• Akkodis: European engineering and digital consulting firm with a life sciences vertical covering regulatory, validation, and quality services. Comparable in qualification/validation and regulated-systems capabilities at greater scale.
• Capgemini Engineering (formerly Altran): Large global engineering and consulting firm with a dedicated life sciences practice covering regulatory, quality, and digital transformation. Competes for enterprise pharma and medtech consulting mandates that overlap with Qualilab's quality and systems services.
• Eurofins Scientific: Global bioanalytical testing and contract research group with regulatory and quality-adjacent service lines. Adjacent to Qualilab's analytical support and quality management offerings, though much larger and more diversified.

Emerging players

• Kymanox: US-headquartered consulting firm providing regulatory, quality, and compliance services to pharma, biotech, and combination product manufacturers. Comparable service portfolio but primarily US-focused; relevant as a US counterpart.

Others

• ICON plc: Global contract research organization providing clinical, regulatory, and laboratory services to pharma and biotech. Adjacent rather than directly overlapping — relevant for client overlap and ecosystem competition, though focused on clinical rather than quality/regulatory consulting.

Direct peers

• Voisin Consulting Life Sciences: France-headquartered regulatory, clinical, and quality consulting firm serving pharma, biotech, and medical device clients across Europe. Directly comparable in vertical focus, regulatory depth, and French/European service mix to Qualilab.
• PQE Group: Italy-based life sciences compliance, qualification/validation, and engineering consulting firm with strong presence in pharma and medical devices. Comparable in regulatory and validation service mix and European footprint.
• BlueReg Group: French consulting firm specializing in regulatory affairs, pharmacovigilance, and quality for pharmaceutical, biotech, and medical device companies. Closely matches Qualilab's regulatory affairs and medical device focus in the French market.
• PharmaLex (Cencora): Global regulatory affairs, quality, and pharmacovigilance consulting firm serving pharma, biotech, and medical device companies. Direct overlap with Qualilab's regulatory affairs, toxicology, and quality management offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ar2i-sa-analyses-recherches-et-innovation-instrumentale

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AR2I